Accuray Incorporated (NASDAQ:ARAY) Q3 2024 Earnings Conference Call May 1, 2024 4:30 PM ET Company Participants Jesse Chew - SVP and Chief Legal Officer Suzanne Winter - President and CEO Ali Pervaiz - CFO Conference Call Participants Young Li - Jefferies Brooks O'Neil - Lake Street Jason Wittes - ROTH MKM Operator Good afternoon, and welcome to the Accuray conference call to review financial results for the third quarter of fiscal year 2024 which ended March 31 of 2024. All participants will be in listen-o ...

分组1 - Accuray reported a quarterly loss of $0.06 per share, missing the Zacks Consensus Estimate of a loss of $0.01, and compared to earnings of $0.01 per share a year ago, indicating an earnings surprise of -500% [1] - The company's revenues for the quarter ended March 2024 were $101.13 million, missing the Zacks Consensus Estimate by 11.75%, and down from $118.06 million year-over-year [1] - Accuray has not surpassed consensus EPS estimates over the last four quarters, and has topped consensus revenue estimates only twice in the same period [1] 分组2 - Accuray shares have declined approximately 24.7% since the beginning of the year, contrasting with the S&P 500's gain of 5.6% [2] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors [2] - The current consensus EPS estimate for the next quarter is $0.07 on revenues of $137.8 million, and for the current fiscal year, it is -$0.07 on revenues of $463.5 million [4] 分组3 - The Zacks Industry Rank places Medical - Instruments in the bottom 44% of over 250 Zacks industries, indicating potential underperformance compared to the top 50% of ranked industries [4] - The trend of estimate revisions for Accuray is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market [3]

Exhibit 99.1 Accuray Reports Fiscal 2024 Third Quarter Financial Results MADISON, Wis, May 1, 2024 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter and nine-months ended March 31, 2024. Third Quarter Fiscal 2024 Summary • Net revenue of $101.1 million decreased 14 percent from the same period in the prior fiscal year. Net revenue on a constant currency basis was $102.4 million, which represented a 13 percent decrease from the same period in the prior fiscal year. ...

Celebrates 30 Years of Innovation Through Collaboration and the Development of Technologies That Have Helped Set the Standard of Care for the Industry MADISON, Wis., April 25, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife® and Radixact® platforms provide medical care teams with the technology necessary for expanding t ...

 The new center is the most recent addition to the company's existing training hubs in Madison, Wisconsin (U.S.), Tokyo, Japan and Tianjin, China  Each facility offers a range of educational opportunities designed to advance patient care using the Accuray CyberKnife® and Radixact® Systems MADISON, Wis., April 18, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that as part of its commitment to advancing patient care the company has opened a new training center in Genolier, Switzer ...

baranozdemir Accuray (NASDAQ:ARAY) is certainly in the running for being one of the most frustrating stocks I’ve followed. While the company has made a lot of smart moves to improve its product portfolio and boost its growth prospects, market share has been frustratingly slow to follow and the stock has languished for years as the company hasn’t been able to really close much of the gap with Varian (owned by Siemens Healthineers (OTCPK:SMMNY)) or Elekta (OTCPK:EKTAY). Since my last update, despite two r ...

A month has gone by since the last earnings report for Accuray (ARAY) . Shares have added about 1.6% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Accuray due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Accuray Q2 Earnings Lag Estimates, Gross Margin Contracts ...

Company to Take Part in Fireside Chat Tuesday, March 12, 2024 at 7:00am PST / 10:00am EST MADISON, Wis., Feb. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference taking place March 12-13, 2024. The management team is scheduled to participate in a fireside chat on Tuesday, March 12, 2024 at 7:00am PST / 10:00am EST. A live webcast of the fireside chat can be accessed on the Accuray website at in ...

While most financial advisors will probably steer you away from under $5 stocks, they have their benefits. Just like in football – the American kind – you can’t just run up the gut.Well, technically, you can. That’s where the phrase three yards and a cloud of dust basically originated. If you hold onto the ball and keep marching down the field, you eat up the clock and deny opportunities to your opposition. However, the problem with this rather unimaginative strategy is that stuff happens.And that stuff – t ...

Accuray Incorporated (ARAY) is well-poised for growth in the coming quarters, courtesy of continued solid demand for its products. The optimism led by the second quarter of fiscal 2024 performance and potential in Precision Treatment Planning System (TPS) are expected to contribute further. However, overdependence on technologies and stiff competition persists.Over the past year, this Zacks Rank #3 (Hold) stock has lost 5.8% against the 9.3% rise of the industry. The S&P 500 has witnessed 25.4% growth in th ...